Infant Bacterial Therapeutics

53,90 SEK

-3,75%

Mindre end 1K følgere

IBT B

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Kvartalsdata

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Infant Bacterial Therapeutics

Q3/24Q4/242024Q1/25Q2/25Q3/25Q4/252025
Omsætning
EBITDA-33,6-37,2-144,5-17,5-19,9-10,6-20,1-68,2
EBIT-33,8-37,4-145,3-17,5-20,1-10,8-20,5-69,0
EBIT-%
Overskud før skat-32,7-33,8-136,9-16,7-19,2-10,1-19,2-65,2
Netto indkomst-32,7-33,8-136,9-16,7-19,2-10,1-19,2-65,2